Cargando…

Decreased Electroencephalography Global Field Synchronization in Slow-Frequency Bands Characterizes Synaptic Dysfunction in Amnestic Subtypes of Mild Cognitive Impairment

BACKGROUND: Mild cognitive impairment (MCI) is highly prevalent in a memory clinic setting and is heterogeneous regarding its clinical presentation, underlying pathophysiology, and prognosis. The most prevalent subtypes are single-domain amnestic MCI (sd-aMCI), considered to be a prodromal phase of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smailovic, Una, Ferreira, Daniel, Ausén, Birgitta, Ashton, Nicholas James, Koenig, Thomas, Zetterberg, Henrik, Blennow, Kaj, Jelic, Vesna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031731/ https://www.ncbi.nlm.nih.gov/pubmed/35462693 http://dx.doi.org/10.3389/fnagi.2022.755454

Ejemplares similares

Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer’s Disease
por: Smailovic, Una, et al.
Publicado: (2021)

Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism
por: Smailovic, Una, et al.
Publicado: (2020)

Decreased Global EEG Synchronization in Amyloid Positive Mild Cognitive Impairment and Alzheimer’s Disease Patients—Relationship to APOE ε4
por: Smailovic, Una, et al.
Publicado: (2021)

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
por: Smailovic, Una, et al.
Publicado: (2019)

Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography
por: Kim, Jae-Gyum, et al.
Publicado: (2022)

EEG time signature in Alzheimer´s disease: Functional brain networks falling apart
por: Smailovic, Una, et al.
Publicado: (2019)

Fluid Biomarkers for Synaptic Dysfunction and Loss
por: Camporesi, Elena, et al.
Publicado: (2020)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

Cohort study of electroencephalography markers of amyloid-tau-neurodegeneration pathology
por: Tanabe, Sean, et al.
Publicado: (2020)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
por: Ashton, Nicholas J., et al.
Publicado: (2019)

Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre‐analytical conditions
por: Simrén, Joel, et al.
Publicado: (2021)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022)

Novel ThickNet features for the discrimination of amnestic MCI subtypes
por: Raamana, Pradeep Reddy, et al.
Publicado: (2014)

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
por: Yilmaz, Aylin, et al.
Publicado: (2019)

Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
por: Bloniecki, Victor, et al.
Publicado: (2020)

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
por: Camporesi, Elena, et al.
Publicado: (2021)

Neurocognitive and Behavioral Indexes for Identifying the Amnestic Subtypes of Mild Cognitive Impairment
por: Cid-Fernández, Susana, et al.
Publicado: (2017)

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Montoliu-Gaya, Laia, et al.
Publicado: (2021)

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
por: Blennow, Kaj, et al.
Publicado: (2015)

The Past and the Future of Alzheimer’s Disease Fluid Biomarkers(1)
por: Blennow, Kaj, et al.
Publicado: (2018)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
por: Zetterberg, Henrik, et al.
Publicado: (2021)

Slowing gait speed precedes cognitive decline by several years
por: Skillbäck, Tobias, et al.
Publicado: (2022)

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
por: Öhrfelt, Annika, et al.
Publicado: (2016)

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
por: Duits, Flora H., et al.
Publicado: (2018)

Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample
por: Arvidsson Rådestig, Maya, et al.
Publicado: (2023)

White Matter Abnormalities in Two Different Subtypes of Amnestic Mild Cognitive Impairment
por: Liu, Jianghong, et al.
Publicado: (2017)

Classification Methods Based on Complexity and Synchronization of Electroencephalography Signals in Alzheimer’s Disease
por: Nobukawa, Sou, et al.
Publicado: (2020)

Detecting Cortical Spreading Depolarization with Full Band Scalp Electroencephalography: An Illusion?
por: Hofmeijer, Jeannette, et al.
Publicado: (2018)

Gamma band functional connectivity reduction in patients with amnestic mild cognitive impairment and epileptiform activity
por: Cuesta, Pablo, et al.
Publicado: (2022)

Association of Plasma and Electroencephalography Markers With Motor Subtypes of Parkinson’s Disease
por: Yang, Xiaoxia, et al.
Publicado: (2022)

Complexity of Wake Electroencephalography Correlates With Slow Wave Activity After Sleep Onset
por: Hou, Fengzhen, et al.
Publicado: (2018)

Fast and Slow Rhythms of Naturalistic Reading Revealed by Combined Eye-Tracking and Electroencephalography
por: Henke, Lena, et al.
Publicado: (2023)

The Effect of Clinical Characteristics and Subtypes on Amyloid Positivity in Patients with Amnestic Mild Cognitive Impairment
por: Kim, Jeong Yeon, et al.
Publicado: (2019)

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
por: Hellwig, Konstantin, et al.
Publicado: (2015)

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons
por: Nazir, Faisal Hayat, et al.
Publicado: (2018)

Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2020)

Biomarkers for tau pathology
por: Schöll, Michael, et al.
Publicado: (2019)

Cortical Source Multivariate EEG Synchronization Analysis on Amnestic Mild Cognitive Impairment in Type 2 Diabetes
por: Cui, Dong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dr9jb91gtq05rp3mf8sc5ocr0g